Advanced Transfusion Medicine Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 5.03 M
as on 07-12-2024
- Company Age 27 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.92 Cr
as on 07-12-2024
- Revenue -10.03%
(FY 2020)
- Profit -12.08%
(FY 2020)
- Ebitda 72.29%
(FY 2020)
- Net Worth 5.56%
(FY 2020)
- Total Assets 4.06%
(FY 2020)
About Advanced Transfusion Medicine Research Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 5.03 M.
The company has closed loans amounting to ₹5.92 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Urmish Chudgar, Mahesh Mohatta, and Jwalant Shah serve as directors at the Company.
- CIN/LLPIN
U19129GJ1997NPL032264
- Company No.
032264
- Company Classification
Public Not For Profit Company
- Incorporation Date
06 May 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Advanced Transfusion Medicine Research Foundation?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Mohatta  | Managing Director | 01-Oct-2002 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Urmish Chudgar | Director | 06-May-1997 | Current |
| Jwalant Shah | Director | 27-Feb-2012 | Current |
Financial Performance of Advanced Transfusion Medicine Research Foundation.
Advanced Transfusion Medicine Research Foundation, for the financial year ended 2020, experienced significant reduction in revenue, with a 10.03% decrease. The company also saw a substantial fall in profitability, with a 12.08% decrease in profit. The company's net worth moved up by a moderate rise of 5.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Transfusion Medicine Research Foundation?
In 2017, Advanced Transfusion Medicine Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unipath Specialty Laboratory LimitedActive 15 years 7 monthsUrmish Chudgar, Mahesh Mohatta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 21 Dec 2012 | ₹1.19 M | Satisfied |
Abn Amro Bank Nv Creation Date: 07 Nov 2007 | ₹1.60 M | Satisfied |
Abn Amro Bank Nv Creation Date: 01 Nov 2007 | ₹1.13 M | Satisfied |
How Many Employees Work at Advanced Transfusion Medicine Research Foundation?
Advanced Transfusion Medicine Research Foundation has a workforce of 58 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Transfusion Medicine Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Transfusion Medicine Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
